心臓モニタリングと心リズム管理機器の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2033年

心臓モニタリングと心リズム管理機器市場の概要

世界の心臓モニタリングと心リズム管理機器市場規模は、2024年に218億4,000万米ドルと推定され、2033年には323億4,000万米ドルに達すると予測され、2025～2033年のCAGRは4.45%で成長すると予測されます。心血管系の罹患率の増加は、市場の成長を促進する重要な要因の一つです。

2025年1月に発表されたオックスフォード・アカデミックの紙製によると、心血管疾患の世界の年齢標準化有病率は人口10万人当たり約7,179例に達しており、心臓疾患が世界的に重大かつ継続的な影響を及ぼしていることが強調されています。このような広範な有病率は、数百万人が合併症を予防するために注意深いモニタリングと適時の介入を必要とする疾患とともに生活していることを意味します。このため、異常な心リズムを特定し、慢性的な心臓疾患を管理し、重篤な心疾患のリスクを低減するために不可欠な心臓モニタリングと心リズム管理機器に対する需要が高まっています。

CVDの早期発見のための啓発キャンペーンや政府主導のスクリーニングプログラムの増加は、より多くの患者がタイムリーな診断と治療を受けられるようにすることで、市場の拡大に貢献しています。Hearst Newspapers II, LLCが2025年6月に発表した記事によると、Midland Memorial HospitalはChampionship Hearts Foundationと協力して、14～18歳の青年を対象に無料の心電図と限定的な心エコー検査を実施しています。これまでのイベントでは、参加者250人に1人の割合で、肥大型心筋症など生命を脅かしかねない重篤な心臓疾患が発見されています。このようなイニシアチブは、若者の突然の心臓事故を予防する上で、早期発見の重要な役割を強調しています。また、小児や青少年の集団に合わせた携帯型ECG機器や先進的リズムモニタリング技術に対するニーズが高まっていることも強調され、心臓モニタリングと心リズム管理機器市場の拡大に寄与しています。

さらに、米国心臓協会（AHA）、米国心臓病学会（ACC）、米国胸部医療会（ACCP）、心リズム学会（HRS）が2023年11月に発表した記事によると、心房細動（AFib）に対する認識を高め、特に高齢者のような高リスク集団の間で定期的なスクリーニングを取り入れることの重要性が強調されています。これらの勧告は、早期診断と効果的な治療を促進するために、定期的な脈拍と心電図のスクリーニングを行うことを提唱しています。心房細動を速やかに発見し、管理することは、脳卒中やその他の深刻な健康問題のリスクを大幅に減らすことができるため、極めて重要です。このような積極的なスクリーニングと教育への注目は、心臓のリズム障害を特定し適切な医療を指導するために不可欠な心臓モニタリングとリズム管理機器の需要を高め、市場の成長を後押ししています。

CVDを対象としたスクリーニングプログラムの効率性が市場の成長を後押ししています。シュプリンガー・ネイチャー誌によると、2024年6月、循環器学に関する報告書のレビューがスクリーニングプログラムの影響を検証しています。AF-SCREENやSTROKESTOPのような多施設研究で得られた知見が強調されており、特に高齢者において、対象を絞ったスクリーニングがCVDの発見を大幅に促進することが示されています。この総説は、心房細動に関連する合併症の負担の増大に対処するため、全国的なスクリーニングイニシアチブを確立することを強く支持し、早期発見と介入の重要な役割を強調しています。

主要企業が提供する技術的に先進的製品は、市場の成長を促進します。例えば、2025年4月、LifeSignals, Inc.はHeart Rhythm 2025でUbiqVue 2AYe Holter Systemを発表しました。UltraLinQ Healthcare Solutionsと共同で販売されるこの新しいホルター・モニタリングソリューションは、従来型方法よりもはるかに迅速に診断レポートを作成し、バイオセンサ装置を郵送したり物理的に回収したりする必要性をなくすことで、心臓モニタリングのワークフローを合理化するように設計されています。

UbiqVueシステムの中核をなす2AYe Biosensoraは、2チャネルのECGとイベントデータを最長5日間連続記録できる使い捨ての胸部装着型機器です。バイオセンサによって収集されたデータは安全に暗号化され、モニタリング期間中、患者向けのモバイルアプリを介してクラウドベースプラットフォームに送信されます。ホルター検査が終了すると、患者のデータはクラウドベースECG分析によって迅速に分析され、認定心臓検査技師が必要とするレビュー時間が大幅に短縮され、医師は数時間以内に最終報告書にアクセスできます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の心臓モニタリングと心リズム管理機器市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 世界の心臓モニタリングと心リズム管理：市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析
• 技術
• 使用事例分析

第4章 世界の心臓モニタリングと心リズム管理機器市場セグメント分析、製品別、2021～2033年

• 定義と範囲
• 製品市場シェア分析、2024年と2033年
• セグメントダッシュボード
• 世界の心臓モニタリングと心リズム管理機器市場（製品別、2021～2033年）
• 心臓モニタリング装置
  • 心臓モニタリング機器市場推定・予測、2021～2033年
  • 心電図
  • 埋め込み型心臓モニター
  • ホルターモニター
  • モバイル心臓テレメトリー
• 心リズム管理機器
  • 心リズム管理機器市場推定・予測、2021～2033年
  • 心臓再同期療法（CRT）
  • 除細動器
  • ペースメーカー

第5章 世界の心臓モニタリングと心リズム管理機器市場セグメント分析、最終用途別、2021～2033年

• 定義と範囲
• 最終用途市場シェア分析、2024年と2033年
• セグメントダッシュボード
• 世界の心臓モニタリングと心リズム管理機器市場（最終用途別、2021～2033年）
• 病院
  • 市場推定・予測、2021～2033年
• 外来手術センター
  • 市場推定・予測、2021～2033年
• その他
  • 市場推定・予測、2021～2033年

第6章 心臓モニタリングと心リズム管理機器市場セグメント分析、地域別、2021～2033年

• 地域別市場シェア分析、2024年と2034年
• 地域別市場ダッシュボード
• 地域市場のスナップショット
• 心臓モニタリングと心リズム管理機器の市場シェア（地域別、2024年と2033年）
• 北米
  • 北米の心臓モニタリングと心リズム管理機器市場、2021～2033年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の心臓モニタリングと心リズム管理機器市場、2021～2033年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業プロファイル
  • Stryker
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • ZOLL Medical Corporation.（Asahi Kasei company）
  • GE HealthCare
  • MicroPort Scientific Corporation
  • NIHON KOHDEN CORPORATION
  • BIoTronik SE & Co KG

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 4 Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 5 Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Region, 2021 - 2033 (USD Million)
• Table 6 North America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Country, 2021 - 2033 (USD Million)
• Table 7 North America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 8 North America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 9 U.S. Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 10 U.S. Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 11 Canada Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 12 Canada Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 13 Mexico Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 14 Mexico Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 15 Europe Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Country, 2021 - 2033 (USD Million)
• Table 16 Europe Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 17 Europe Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 18 UK Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 19 UK Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 20 Germany Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 21 Germany Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 22 France Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 23 France Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 24 Italy Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 25 Italy Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 26 Spain Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 27 Spain Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 28 Denmark Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 29 Denmark Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 30 Sweden Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 31 Sweden Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 32 Norway Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 33 Norway Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 34 Asia Pacific Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Country, 2021 - 2033 (USD Million)
• Table 35 Asia Pacific Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 36 Asia Pacific Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 37 Japan Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 38 Japan Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 39 China Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 40 China Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 41 India Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 42 India Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 43 Australia Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 44 Australia Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 45 Thailand Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 46 Thailand Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 47 South Korea Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 48 South Korea Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 49 Latin America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Country, 2021 - 2033 (USD Million)
• Table 50 Latin America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 51 Latin America Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 52 Brazil Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 53 Brazil Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 54 Argentina Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 55 Argentina Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 56 Middle East & Africa Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Country, 2021 - 2033 (USD Million)
• Table 57 Middle East & Africa Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Product, 2021 - 2033 (USD Million)
• Table 58 Middle East & Africa Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 59 South Africa Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 60 South Africa Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 61 Saudi Arabia Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 62 Saudi Arabia Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 63 UAE Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 64 UAE Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)
• Table 65 Kuwait Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033 (USD Million)
• Table 66 Kuwait Cardiac Monitoring And Cardiac Rhythm Management Devices Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Global cardiac monitoring and cardiac rhythm management market: outlook
• Fig. 9 Global cardiac monitoring and cardiac rhythm management competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Ancillary market outlook
• Fig. 12 Global cardiac monitoring and cardiac rhythm management devices market driver impact
• Fig. 13 Global cardiac monitoring and cardiac rhythm management devices market restraint impact
• Fig. 14 Porter's Analysis
• Fig. 15 PESTLE Analysis
• Fig. 16 Global cardiac monitoring and cardiac rhythm management market: Product movement analysis
• Fig. 17 Global cardiac monitoring and cardiac rhythm management market: Product outlook and key takeaways
• Fig. 18 Cardiac monitoring devices market estimates and forecast, 2021 - 2033
• Fig. 19 ECG market estimates and forecast, 2021 - 2033
• Fig. 20 Implantable cardiac monitors market estimates and forecast, 2021 - 2033
• Fig. 21 Holter monitors market estimates and forecast, 2021 - 2033
• Fig. 22 Mobile cardiac telemetry market estimates and forecast, 2021 - 2033
• Fig. 23 Cardiac rhythm management devices market estimates and forecast, 2021 - 2033
• Fig. 24 Cardiac Resynchronization Therapy (CRT) market estimates and forecast, 2021 - 2033
• Fig. 25 CRT-defibrillator market estimates and forecast, 2021 - 2033
• Fig. 26 CRT-pacemakers market estimates and forecast, 2021 - 2033
• Fig. 27 Defibrillator market estimates and forecast, 2021 - 2033
• Fig. 28 Implantable Cardioverter Defibrillators (ICD) market estimates and forecast, 2021 - 2033
• Fig. 29 Single chamber market estimates and forecast, 2021 - 2033
• Fig. 30 Dual chamber market estimates and forecast, 2021 - 2033
• Fig. 31 External defibrillator market estimates and forecast, 2021 - 2033
• Fig. 32 Manual external defibrillator market estimates and forecast, 2021 - 2033
• Fig. 33 Automatic external defibrillator market estimates and forecast, 2021 - 2033
• Fig. 34 Wearable cardioverter defibrillator market estimates and forecast, 2021 - 2033
• Fig. 35 Pacemakers market estimates and forecast, 2021 - 2033
• Fig. 36 Conventional market estimates and forecast, 2021 - 2033
• Fig. 37 Leadless market estimates and forecast, 2021 - 2033
• Fig. 38 Global cardiac monitoring and cardiac rhythm management market: End use movement analysis
• Fig. 39 Global cardiac monitoring and cardiac rhythm management market: End use outlook and key takeaways
• Fig. 40 Hospitals market estimates and forecasts, 2021 - 2033
• Fig. 41 Ambulatory surgery centers market estimates and forecasts,2021 - 2033
• Fig. 42 Others market estimates and forecasts,2021 - 2033
• Fig. 43 Global cardiac monitoring and cardiac rhythm management devices market: Regional outlook and key takeaways
• Fig. 44 North America cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 U.S. cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Canada cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Mexico cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 51 Europe cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033, (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 UK cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Germany cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Spain cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 France cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Italy cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Norway cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Denmark cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Sweden cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 68 Asia Pacific cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033, (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Japan cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 China cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 India cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Australia cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 South Korea cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Thailand cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 81 Latin America cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033, (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Brazil cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Argentina cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 86 MEA cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 South Africa cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 Saudi Arabia cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 UAE cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 Kuwait cardiac monitoring and cardiac rhythm management devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 95 Key company categorization
• Fig. 96 Heat map analysis 2024

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Summary

The global cardiac monitoring and cardiac rhythm management devices market size was estimated at USD 21.84 billion in 2024 and is projected to reach USD 32.34 billion by 2033, growing at a CAGR of 4.45% from 2025 to 2033. Increasing cardiovascular incidence is one of the key factors driving the market's growth.

According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches about 7,179 cases per 100,000 people, emphasize the significant and ongoing impact of heart conditions globally. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. This fuels demand for cardiac monitoring and cardiac rhythm management devices, which are critical for identifying abnormal heart rhythms, managing chronic heart conditions, and reducing the risk of serious cardiac events.

Increasing awareness campaigns and government-initiated screening programs for early detection of CVDs contribute to market expansion by ensuring more patients receive timely diagnosis and treatment. According to an article published by Hearst Newspapers II, LLC in June 2025, Midland Memorial Hospital, working alongside the Championship Hearts Foundation, conducts free ECG and limited echocardiogram screenings for teenagers between 14 and 18 years old. In previous events, these screenings identified severe, potentially life-threatening heart conditions, such as hypertrophic cardiomyopathy, in approximately 1 out of every 250 participants. Initiatives like this highlight the critical role of early detection in preventing sudden cardiac events among young people. They also emphasize the growing need for portable ECG devices and advanced rhythm-monitoring technologies tailored for pediatric and adolescent populations, contributing to expanding the cardiac monitoring and cardiac rhythm management devices market.

Furthermore, according to the American Heart Association, Inc. article published in November 2023, the 2023 guidelines issued by the American Heart Association (AHA), American College of Cardiology (ACC), American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) emphasize the importance of increasing awareness and incorporating routine screening for atrial fibrillation (AFib), especially among high-risk groups like older adults. These recommendations advocate for regular pulse and ECG screenings to facilitate early diagnosis and effective treatment. Detecting and managing AFib promptly is vital because it can substantially reduce the risk of stroke and other serious health problems. This focus on proactive screening and education drives up demand for cardiac monitoring and rhythm management devices, which are essential for identifying heart rhythm disorders and guiding proper medical care, thereby boosting market growth.

The efficiency of targeted screening programs for CVDs fuels market growth. According to Springer Nature, in June 2024,a review of cardiology reports examines the impact of screening programs. It highlights findings from multicenter studies, such as AF-SCREEN and STROKESTOP, which show that targeted screening greatly enhances the detection of CVDs, especially among older adults. The review strongly supports establishing national screening initiatives to address the growing burden of AFib-related complications, highlighting the critical role of early detection and intervention.

The technologically advanced products offered by the key players drive the market's growth. For instance, in April 2025, LifeSignals, Inc. introduced the UbiqVue 2AYe Holter System at Heart Rhythm 2025. This new Holter monitoring solution, distributed in collaboration with UltraLinQ Healthcare Solutions, is designed to streamline cardiac monitoring workflows by producing diagnostic reports far faster than traditional methods and eliminating the need to mail or physically retrieve the biosensor device.

At the heart of the UbiqVue system is the 2AYe Biosensora, a disposable, chest-worn device capable of continuously recording two-channel ECG and event data for up to five days. Data collected by the biosensor is securely encrypted and sent via a patient-facing mobile app to a cloud-based platform during the monitoring period. Once the Holter test concludes, the patient's data is quickly analyzed through cloud-based ECG analytics, substantially reducing the review time required by certified cardiac technicians and enabling physicians to access finalized reports within hours.

Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. For this report, Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management devices market report based on product, end use, and region:

• Product Outlook (Revenue USD Million, 2021 - 2033)
• Cardiac Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
• Cardiac Rhythm Management Devices
  • Cardiac Resynchronization Therapy (CRT)
  • CRT-Defibrillator
  • CRT-Pacemakers
  • Defibrillator
  • Implantable Cardioverter Defibrillators (ICD)
  • Single Chamber
  • Dual Chamber
  • External Defibrillator
  • Manual External Defibrillator
  • Automatic External Defibrillator
  • Wearable Cardioverter Defibrillator
  • Pacemakers
  • Conventional
  • Leadless
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising cardiovascular incidence
    • 3.2.1.2. Increasing awareness and screening programs for cardiac cases
    • 3.2.1.3. Technological advancements in cardiac monitoring & rhythm management devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost associated with devices
    • 3.2.2.2. Product recalls
• 3.3. Global Cardiac Monitoring And Cardiac Rhythm Management: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by Product, 2021 to 2033
• 4.5. Cardiac Monitoring Devices
  • 4.5.1. Cardiac monitoring devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. ECG
    • 4.5.2.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. Implantable cardiac monitors
    • 4.5.3.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. Holter Monitors
    • 4.5.4.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.5. Mobile Cardiac Telemetry
    • 4.5.5.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Cardiac Rhythm Management Devices
  • 4.6.1. Cardiac rhythm management devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Cardiac Resynchronization Therapy (CRT)
    • 4.6.2.1. Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.2.1.1. CRT-Defibrillator
        • 4.6.2.1.1.1. CRT-Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.2.1.2. CRT-Pacemakers
        • 4.6.2.1.2.1. CRT-Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Defibrillator
    • 4.6.3.1. Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.3.1.1. Implantable Cardioverter Defibrillators (ICD)
        • 4.6.3.1.1.1. Implantable Cardioverter Defibrillators (ICD) market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.1.2. Single Chamber
          • 4.6.3.1.1.2.1. Single Chamber market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.1.3. Dual Chamber
          • 4.6.3.1.1.3.1. Dual Chamber market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.3.1.2. External Defibrillator
        • 4.6.3.1.2.1. External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.2. Manual External Defibrillator
          • 4.6.3.1.2.2.1. Manual External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.3. Automatic External Defibrillator
          • 4.6.3.1.2.3.1. Automatic External Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.6.3.1.2.4. Wearable Cardioverter Defibrillator
          • 4.6.3.1.2.4.1. Wearable Cardioverter Defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. Pacemakers
    • 4.6.4.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.4.1.1. Conventional
        • 4.6.4.1.1.1. Conventional market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.6.4.1.2. Leadless
        • 4.6.4.1.2.1. Leadless market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market, by End Use, 2021 to 2033
• 5.5. Hospitals
  • 5.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Ambulatory Surgery Centers
  • 5.6.1. Ambulatory surgery centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 6. Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2034
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Cardiac Monitoring And Cardiac Rhythm Management Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait cardiac monitoring and cardiac rhythm management devices market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Stryker
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Medtronic
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Abbott
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Boston Scientific Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Koninklijke Philips N.V.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. ZOLL Medical Corporation. (Asahi Kasei company)
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. GE HealthCare
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. MicroPort Scientific Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. NIHON KOHDEN CORPORATION
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Biotronik SE & Co KG
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives